Past Events and Resources

The Future of Health Care and Morality of Medicine in an AI World
Category : WYNG-Hatton Lecture
Date : 25 Nov, 2019
Time : 5:45 pm – 7:00 pm
Venue : Large Moot Court, 2/F, Cheng Yu Tung Tower, Centennial Campus, The University of Hong Kong



Artificial Intelligence is infiltrating healthcare at a breakneck pace. New technologies will soon diagnose and treat disease better and faster than even the most expertly trained human specialists. But what will be the impact on the morality of medicine from these technologies?  This lecture will discuss how AI will affect the human side of health care -- the interactions between patients, families and clinicians.
Dr. Eric M. Meslin, PhD, FCAHS

Dr. Meslin is President and CEO of the Council of Canadian Academies, a not-for-profit organization that conducts evidence-based expert assessments of leading policy topics in climate, health, energy, S&T policy, indigenous affairs, and public safety for the Government of Canada.

Trained as a philosopher and bioethicist, Dr. Meslin’s academic career included 15 years at Indiana University as Founding Director of the Indiana University Center for Bioethics, Associate Dean for Bioethics in the School of Medicine, and Professor of Medicine, of Medical & Molecular Genetics, of Bioethics & Law, of Public Health, and of Philosophy. Dr. Meslin has held academic positions at University of Toronto, the University of Western Australia, and Universitè de Toulouse. He is a Senior Fellow, PHG Foundation, University of Cambridge, and an Academic Affiliate in the Nuffield Department of Population Health, University of Oxford.  He has published more than 200 articles and book chapters, and two co-edited books on ethical and policy issues in genomics, global health, science policy and human subjects research. 

He has had an equally productive administrative and policy career. He was Bioethics Research Director of the Ethical, Legal, and Social Implications (ELSI) program at the National Human Genome Research Institute in the early years of the Human Genome Project, and then Executive Director of the U.S. National Bioethics Advisory Commission established by President Bill Clinton.

Subscribe to our newsletters and updates